Source comparison
Injection Site Selection and Systemic vs Local Administration
Subcutaneous administration in abdominal tissue produces systemic distribution. TB-500 and GHK-Cu circulate through the bloodstream and reach tissues throughout the body. This approach works for generalized repair signaling but dilutes local tissue concentrati
This comparison does not assign a generated winner or score.
- Subcutaneous administration in abdominal tissue produces systemic distribution. TB-500 and GHK-Cu circulate through the bloodstream and reach tissues throughout the body. This approach works for generalized repair signaling but dilutes local tissue concentration significantly. For targeted repair (rotator cuff tendinopathy, meniscus damage, post-surgical incision sites), peri-injury injection delivers 8–12× higher peptide concentration to the affected tissue compared to systemic administration.
- When using local injection, the 6–8 hour stagger becomes even more critical. Injecting both peptides at the same site simultaneously creates a peptide "traffic jam". Fibroblast receptors become saturated with competing ligands, and much of the injected dose diffuses away from the site before cellular uptake occurs. Staggering by 6–8 hours allows the first peptide (TB-500) to bind available receptors and initiate its signaling cascade, then those receptors recycle and become available for GHK-Cu binding during the second administration window.
- Injection volume also matters for local administration. TB-500 at 2.5mg reconstituted in 0.5mL bacteriostatic water creates a concentrated depot that stays localized for 4–6 hours. GHK-Cu at 1.5mg in 0.3mL creates a similarly concentrated depot. Diluting either peptide into larger volumes (1–2mL) increases diffusion radius but reduces peak local concentration. Acceptable for systemic protocols, counterproductive for targeted repair.